Next-generation sequencing revealed a pathogenic RB1 mutation within the ependymoma component of case #33 with the other allele being affected by a deletion on chr13, whereas the subependymoma component of the same tumor did not show any chromosomal alterations on chr13 (Fig. 3b). This evidence concerns the gene RB1 and neoplasm.